medigraphic.com

2025, Number 1

<< Back Next >>

Enf Infec Microbiol 2025; 45 (1)

Policies for the prevention of nosocomial infections and surveillance criteria implemented in a cancer centre. 35 years of experience

Volkow P, De la Rosa M, Rivas PE, Cornejo JP, Vilar CD, Chávez CTG, Gordillo P, García PB

Language: Spanish
References: 30
Page: 30-39
PDF size: 353.03 Kb.


ABSTRACT

In 1998, the Center for Disease Control and Prevention (CDC), published the first definition for the standarization of surveillance of hospital-acquired infections, in order to make them comparable between different hospital institution and made is possible for preventive interventions to evolve in the clinical care os hospitalized patients.
objetive: to describe the experience of preventive policies and the adequacy of surveillance definitions for episodes of healthcare-associated infections (HAIs) in a care center for adult cancer patiens in Mexico City for 35 yaers, from1990 to 2023.


REFERENCES

  1. LaForce, F.M., “The control of infections in hospitals:1750-1950”. En Wenzel RP (ed.), Prevention andcontrol of nosocomial infections, 2ª ed., Nueva York,Williams & Wilkins, 1993, pp. 1-12.

  2. Garner, J.S., Jarvis, W.R., Emori, T.G., Horan, T.C. y Hughes,J.M., “cdc definitions for nosocomial infections,1988”, Am J Infect Control, 1988, 16 (3): 128-140. doi:10.1016/0196-6553(88)90053-3. Errata en: Am J InfectControl, 1988, 16 (4): 177.

  3. Volkow, P., Chávez-Chávez, T.G., García-Pineda, B., Velázquez-Acosta, C., Carpio-Guadarrama, D., Vilar-Compte,D. e Ibanes-Gutiérrez, C., “Pseudomonas fluorescenscrbsi outbreak: complying with the standardization ofinvasive procedures is a step ahead in the fight againstantimicrobial resistance”, Antimicrob Resist Infect Control,2024, 13 (1): 40.

  4. Volkow, P., Sánchez-Mejorada, G., De la Vega, S.L., Vázquez,C., Téllez, O., Báez, R.M., Aguilar, C., Alfeiran, A.,Zínser, J.W. y Mohar, A., “Experience of an intravenoustherapy team at the Instituto Nacional de Cancerología(Mexico) with a long-lasting, low-cost silastic venouscatheter”, Clin Infect Dis, 1994, 18 (5): 719-725.

  5. Volkow, P., Téllez, O., Vázquez, C., Aguilar, C., Valencia,M., Barrera, L., Alferian, A., Zínser, J., Sobrevilla, P., Acosta,A., Texcocano, J., Vilar-Compte, D. y Reynoso, E., “Asingle, double lumen high-flow catheter for patientsundergoing peripheral blood stem cell transplantation.Experience at the National Cancer Institute in Mexico”,Bone Marrow Transplant, 1997, 20 (9): 779-783.

  6. Volkow, P., Manual del manejo ambulatorio de la terapiaintravenosa para el enfermo con cáncer, México, InstitutoNacional de Cancerología-uteha-Noriega Editores, 2001.

  7. Volkow, P., Vázquez, C., Téllez, O., Aguilar, C., Barrera,L., Rodríguez, E. et al., “Polyurethane ii catheter as long- indwelling intravenous catheter in patients with cancer”,Am J Infect Control, 2003, 31 (7): 392-396.

  8. Finelberg, Z. y Kunin, C.M., “Clinical evaluation of closedurinary drainage systems”, jama, 1969, 207 (9):1657-1662.

  9. Thornton, G.F. y Andriole, V.T., “Bacteriuria during indwellingcatheter drainage. ii. Effect of a closed steriledrainage system”, jama, 1970, 214 (2): 339-342.

  10. Vilar-Compte, D., Sandoval, S., Gordillo, P., De la Rosa,M., Sánchez-Mejorada, G. y Volkow, P., “Surveillance ofsurgical wound infections. 18-month experience in theInstituto Nacional de Cancerología”, Salud Pública Mex,1999, 41 Suppl 1: S44-S50.

  11. Vilar-Compte, D., Mohar, A., Sandoval, S., De la Rosa,M., Gordillo, P. y Volkow, P., “Surgical site infections atthe National Cancer Institute in Mexico: a case-controlstudy”, Am J Infect Control, 2000, 28 (1): 14-20.

  12. Vilar-Compte, D., Jacquemin, B., Díaz-González, A., Velásquez,C. y Volkow, P., “Pseudomonas aeruginosa outbreak,in the area of surgical wound ambulatory care,in postmastectomy patients”, Salud Pública Mex, 2003,45 (5): 371-378.

  13. Vilar-Compte, D., Roldán-Marín, R., Robles-Vidal, C.y Volkow, P., “Surgical site infection (ssi) rates amongpatients who underwent mastectomy after the introductionof ssi prevention policies”, Infect Control HospEpidemiol, 2006, (8): 829-834.

  14. Volkow, P., Sandoval, S., Campos, A.M., Gutiérrez, M.,De Romero, C., Viana Aguiluz, J.J. y Pérez Padilla, J.R.,“Increase in catheter insertion-site infections associatedto the introduction of a substandard competitiveantiseptic”, Am J Infect Control, 2006, (6): 335-337.

  15. Blijlevens, N.M., Donnelly, J.P. y De Pauw, B.E., “Mucosalbarrier injury: biology, pathology, clinical counterpartsand consequences of intensive treatment forhaematological malignancy: an overview”, Bone MarrowTransplant, 2000, 25 (12): 1269-1278.

  16. Peterson, D.E. y Cariello, A., “Mucosal damage: a majorrisk factor for severe complications after cytotoxic therapy”,Semin Oncol, 2004, 31 (3 Suppl 8): 35-44.

  17. Donnelly, J.P., Muus, P., Schattenberg, A., De Witte, T.,Horrevorts, A. y De Pauw, B.E., “A scheme for daily monitoringof oral mucositis in allogeneic bmt recipients”,Bone Marrow Transplant, 1992, 9 (6): 409-413.

  18. CDC, 2013. Disponible en: https://www.cdph.ca.gov/programs/hai/Documents/Slide-Set-20-Infection-Definitions-NHSN-2013.pdf.

  19. See, I., Iwamoto, M., Allen-Bridson, K., Horan, T., Magill,S.S. y Thompson, N.D., “Mucosal barrier injury laboratory-confirmed bloodstream infection: results from afield test of a new National Healthcare Safety Networkdefinition”, Infect Control Hosp Epidemiol, 2013, 34 (8):

  20. 769-776.Volkow, P., Alatorre, P., Lozano, V.H. y Cornejo-JuárezP., “Mucosal barrier injury laboratory confirmed bloodstream”,Infections Curr Treat Options Infect Dis. doi10.1007/s40506-018-0167-7.

  21. Vilar-Compte, D. y García-Pasquel, M.J., “Profilaxis antimicrobianaperioperatoria en cirugía oncológica, RevInvest Clin, 2011, 63 (6): 630-640.

  22. Vilar-Compte, D. e Islas-Muñoz, B.D., “Profilaxis antimicrobianaperioperatoria”. En Granados-García, M., Arrieta-Rodríguez, O.G. e Hinojosa-Gómez, J., Tratamientodel cáncer. Oncología médica, quirúrgica y radioterapia,México, El Manual Moderno, 2016, pp. 928-938.

  23. Volkow, P., Sánchez-Girón, F., Rojo-Gutiérrez, L. y Cornejo-Juárez, P., “Hospital-acquired waterborne bloodstreaminfection by Acinetobacter baumannii from tap water:a case report”, Infect Dis Clin Pract, 2013, 21: 405-406.Normal Oficial Mexicana nom_045_ssa2-2005, Numeral10.6.7.10.

  24. Cornejo-Juárez, P., Cevallos, M.A., Castro-Jaimes, S. etal., “High mortality in an outbreak of multidrug resistantAcinetobacter baumannii infection introduced to an oncologicalhospital by a patient transferred from a generalhospital”, plos One, 2020, 15 (7): e0234684.

  25. Cornejo-Juárez, P., Volkow-Fernández ,P., Sifuentes-Osornio,J., Echániz-Avilés, G., Díaz-González, A., Velázquez-Acosta, C., Bobadilla-Del Valle, M., Gordillo-Molina,P. y Velázquez-Meza, M.E., “Tracing the source of anoutbreak of methicillin-resistant Staphylococcus aureusin a tertiary-care oncology hospital by epidemiology andmolecular methods”, Microb Drug Resist, 2010, 16 (3):203-208. doi: 10.1089/mdr.2010.0048. pmid: 20735171.

  26. De la Rosa-Martínez, D., Rivera-Buendía, F., Cornejo-Juárez, P., García-Pineda, B., Nevárez-Luján, C. y Vilar-Compte, D., “Risk factors and clinical outcomes forClostridioides difficile infections in a case control studyat a large cancer referral center in Mexico”, Am J InfectControl, 2022, 50 (11): 1220-1225.

  27. Onraët, A., Barrientos-Flores, C., Vilar-Compte, D., Pérez-Jiménez, C. y Alatorre-Fernández, P., “Use of remdesivirfor covid-19 in patients with hematologic cancer”, ClinExp Med, 2023, 23 (6): 2231-2238. doi: 10.1007/s10238-022-00964-4. Epub 2022 Dec 12. pmid: 36508048; pmcid:pmc9744041.

  28. Villaseñor-Echavarri, R., Gómez-Romero, L., Martin-Onraët,A., Herrera, L.A., Escobar-Arrazola, M.A., Ramírez-Vega, O.A., Barrientos-Flores, C., Mendoza-Vargas,A., Hidalgo-Miranda, A., Vilar-Compte, D. y Cedro-Tanda,A., “sars-cov-2 genome variations in viral shedding of animmunocompromised patient with non-Hodgkin’s lymphoma”,Viruses, 2023, 15(2): 377.

  29. Volkow, P., García-Aranda, H., Vázquez-Gutiérrez, A.A.,Lárraga-Mancilla, V., Dávila, A., Velázquez, C., Guerrero-Ixtláhuac, J., y Cornejo-Juárez, P., “Incidence of urinarytract infections in patients with permanent percutaneousnephrostomy after implementation of a standardized careprogram”, Gac Med Mex, 2024, 160 (1): 39-44.

  30. Alatorre-Fernández, P., Mayoral-Terán, C., Velázquez-Acosta,C., Franco-Rodríguez, C., Flores-Moreno, K., Cevallos,M.Á., López-Vidal, Y. y Volkow-Fernández, P., “A polyclonaloutbreak of bloodstream infections by Enterococcusfaecium in patients with hematologic malignancies”,Am J Infect Control, 2017, 45 (3): 260-266.




2020     |     www.medigraphic.com